HESUB

"High Efficient, Single-Use-Bioreactor simulating mammalian tissue conditions for expression and proliferation"

Coordinatore	KUNGLIGA TEKNISKA HOEGSKOLAN    more  Organization address address: Valhallavaegen 79 city: STOCKHOLM postcode: 10044 contact info Titolo: Mr. Nome: åke Cognome: Eriksson Email: send email Telefono: +46 8 5537 8288
Nazionalità Coordinatore	Sweden [SE]
Totale costo	7˙592˙834 €
EC contributo	5˙752˙150 €
Programma	FP7-HEALTH Specific Programme "Cooperation": Health
Code Call	FP7-HEALTH-2013-INNOVATION-2
Funding Scheme	CP-FP
Anno di inizio	2013
Periodo (anno-mese-giorno)	2013-05-01   -   2016-04-30

 Partecipanti

#	participant	country	role	EC contrib. [€]
1	KUNGLIGA TEKNISKA HOEGSKOLAN  Organization address address: Valhallavaegen 79 city: STOCKHOLM postcode: 10044 contact info Titolo: Mr. Nome: åke Cognome: Eriksson Email: send email Telefono: +46 8 5537 8288	SE (STOCKHOLM)	coordinator	1˙291˙458.00
2	STOBBE TECH AS  Organization address address: MALMMOSEVEJ 19c city: HOLTE postcode: 2840 contact info Titolo: Mr. Nome: Flemming Cognome: Petersen Email: send email Telefono: +45 45423393 Fax: +45 45424393	DK (HOLTE)	participant	1˙795˙800.00
3	PRESENS PRECISION SENSING GMBH  Organization address address: Josef Engert Strasse 9 city: Regensburg postcode: 93053 contact info Titolo: Mr. Nome: Christian Cognome: Krause Email: send email Telefono: +49 94194272112	DE (Regensburg)	participant	922˙000.00
4	3H BIOMEDICAL AB  Organization address address: DAG HAMMARSKJOLDS VAG 34A city: UPPSALA postcode: 751 83 contact info Titolo: Mrs. Nome: Mallen Cognome: Huang Email: send email Telefono: +46 18504400	SE (UPPSALA)	participant	898˙850.00
5	THE ELECTROSPINNING COMPANY LTD  Organization address address: WATERMARK WAY 10 city: HERTFORD postcode: SG13 7TZ contact info Titolo: Mr. Nome: Robert Cognome: Mckean Email: send email Telefono: +44 1235567278	UK (HERTFORD)	participant	844˙042.00

Mappa

 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

 Obiettivo del progetto (Objective)

A unique combination of earlier EU funded projects allow four research SME´s to create a combined most visionary and innovative product for improved health. There is a strategic decision from pharmaceutical companies and hospitals for: 1. continues expressing of biologicals to fulfill the expectation to “personalized medicine” and 2. proliferation of cells to support therapeutic applications and 3. proliferation of stem cells to prepare manufacturing of real “human spare parts”. Advanced process control inside tailor made and cell harboring scaffolds integrated in a High-Efficient-Single-Use-Bioreactor simulating mammalian tissue conditions will fulfill this requirements